Publications

Reply to "Mepolizumab in patients with eosinophilic granulomatosis with polyangiitis in remission: What is the right dose?"  (2021)

Authors:
Caminati, Marco; Crisafulli, Ernesto; Lunardi, Claudio; Micheletto, Claudio; Festi, Giuliana; Maule, Matteo; Giollo, Alessandro; Orsolini, Giovanni; Senna, Gianenrico
Title:
Reply to "Mepolizumab in patients with eosinophilic granulomatosis with polyangiitis in remission: What is the right dose?"
Year:
2021
Type of item:
Articolo in Rivista
Tipologia ANVUR:
Articolo su rivista
Language:
Inglese
Referee:
No
Name of journal:
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. IN PRACTICE
ISSN of journal:
2213-2198
N° Volume:
9
Number or Folder:
7
Page numbers:
2943-2944
Keyword:
english
Short description of contents:
egpa and mepolizumab
Product ID:
131328
Handle IRIS:
11562/1083714
Last Modified:
March 28, 2023
Bibliographic citation:
Caminati, Marco; Crisafulli, Ernesto; Lunardi, Claudio; Micheletto, Claudio; Festi, Giuliana; Maule, Matteo; Giollo, Alessandro; Orsolini, Giovanni; Senna, Gianenrico, Reply to "Mepolizumab in patients with eosinophilic granulomatosis with polyangiitis in remission: What is the right dose?" «JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. IN PRACTICE» , vol. 9 , n. 72021pp. 2943-2944

Consulta la scheda completa presente nel repository istituzionale della Ricerca di Ateneo IRIS

<<back

Activities

Research facilities

Share